MX2010003036A - Composicion farmaceutica de liberacion controlada ph dependiente para no opioides con resistencia a la influencia del etanol. - Google Patents
Composicion farmaceutica de liberacion controlada ph dependiente para no opioides con resistencia a la influencia del etanol.Info
- Publication number
- MX2010003036A MX2010003036A MX2010003036A MX2010003036A MX2010003036A MX 2010003036 A MX2010003036 A MX 2010003036A MX 2010003036 A MX2010003036 A MX 2010003036A MX 2010003036 A MX2010003036 A MX 2010003036A MX 2010003036 A MX2010003036 A MX 2010003036A
- Authority
- MX
- Mexico
- Prior art keywords
- weight
- pharmaceutical composition
- opioids
- controlled release
- polymer mixture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invenci?n le interesa trata sobre una composici?n farmac?utica de liberaci?n controlada pH dependiente, que consta de al menos un ingrediente activo farmac?utico, con la excepci?n de opioides, en donde el n?cleo se encuentra revestido al menos por una capa de revestimiento, que controle la liberaci?n de composici?n farmac?utica, en donde la capa de revestimiento est? compuesta por una mezcla polim?rica de i) 40 - 95% por peso, con base en el peso en seco de la mezcla polim?rica, de al menos un pol?mero o copol?mero de vinilo esencialmente neutral e insoluble en agua, y ii) 5 - 60% por peso, con base en el peso en seco de la mezcla polim?rica, de al menos un pol?mero o copol?mero ani?nico, que es insoluble en un medio amortiguado por debajo de un pH de 4.0 y soluble al menos en un rango de pH de 7.0 a 8.0. que se caracteriza porque la capa de revestimiento adem?s contiene 110 a 250% por peso, calculado en el peso en seco de la mezcla polim?rica, de un lubricante inerte no poroso y el revestimiento se encuentra presente en una cantidad de al menos 60% por peso calculado en el peso del n?cleo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2136CH2007 | 2007-09-21 | ||
| PCT/EP2007/060130 WO2009036811A1 (en) | 2007-09-21 | 2007-09-25 | Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010003036A true MX2010003036A (es) | 2010-04-09 |
Family
ID=39278276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010003036A MX2010003036A (es) | 2007-09-21 | 2007-09-25 | Composicion farmaceutica de liberacion controlada ph dependiente para no opioides con resistencia a la influencia del etanol. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9555006B2 (es) |
| EP (1) | EP2187875B1 (es) |
| JP (1) | JP5204846B2 (es) |
| KR (1) | KR101454056B1 (es) |
| CN (1) | CN101801356B (es) |
| BR (1) | BRPI0722042B8 (es) |
| CA (1) | CA2699224C (es) |
| ES (1) | ES2393805T3 (es) |
| IL (1) | IL203870A (es) |
| MX (1) | MX2010003036A (es) |
| PL (1) | PL2187875T3 (es) |
| SI (1) | SI2187875T1 (es) |
| WO (1) | WO2009036811A1 (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5965583B2 (ja) | 2007-08-13 | 2016-08-10 | インスピリオン デリバリー テクノロジーズ エルエルシー | 乱用抵抗性医薬組成物、その使用方法および作製方法 |
| PL2326313T3 (pl) | 2008-09-24 | 2015-08-31 | Evonik Roehm Gmbh | Kompozycja farmaceutyczna o zależnym od pH kontrolowanym uwalnianiu dla nieopioidów z odpornością przed wpływem etanolu |
| CN102164588B (zh) * | 2008-09-24 | 2015-07-08 | 赢创罗姆有限公司 | 耐受乙醇影响的pH依赖性受控释放的药物组合物 |
| WO2010057869A1 (en) * | 2008-11-18 | 2010-05-27 | Ucb Pharma, S.A. | Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate |
| AU2009317280B2 (en) | 2008-11-18 | 2014-03-06 | Ucb Pharma, S.A. | Prolonged release formulations comprising an 2 -oxo- 1 -pyrrolidine derivative |
| CN102355893A (zh) | 2009-03-18 | 2012-02-15 | 赢创罗姆有限公司 | 采用含有中性乙烯基聚合物和赋形剂的包衣的具有耐乙醇影响的控释药物组合物 |
| CA2994873A1 (en) | 2009-12-02 | 2011-06-09 | Adamas Pharmaceuticals, Inc. | Amantadine compositions and methods of use |
| US9877925B2 (en) | 2010-05-14 | 2018-01-30 | Ethypharm | Alcohol-resistant oral pharmaceutical form |
| US20130059010A1 (en) * | 2010-05-14 | 2013-03-07 | Ethypharm | Alcohol-resistant oral pharmaceutical form |
| BR112013027484A8 (pt) * | 2011-06-17 | 2022-07-05 | Evonik Roehm Gmbh | Composição farmacêutica ou nutracêutica com resistência gástrica, e uso de um polímero de (met)acrilato |
| US9844511B2 (en) * | 2011-06-17 | 2017-12-19 | Evonik Roehm Gmbh | Coating composition suitable for pharmaceutical or nutraceutical dosage forms |
| US9668977B2 (en) | 2011-06-17 | 2017-06-06 | Evonik Röhm Gmbh | Coating composition suitable for pharmaceutical or nutraceutical dosage forms |
| CA2900781A1 (en) * | 2013-02-13 | 2014-08-21 | Evonik Rohm Gmbh | Multiparticulate pharmaceutical composition comprising a multitude of two kinds of pellets |
| US20140275150A1 (en) | 2013-03-15 | 2014-09-18 | Inspirion Delivery Technologies, Llc | Abuse deterrent compositions and methods of use |
| US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
| US20150352140A1 (en) * | 2014-06-07 | 2015-12-10 | Api Intellectual Property Holdings, Llc | Biomass-based dietary supplement |
| US10729685B2 (en) | 2014-09-15 | 2020-08-04 | Ohemo Life Sciences Inc. | Orally administrable compositions and methods of deterring abuse by intranasal administration |
| CN105769823A (zh) * | 2014-12-24 | 2016-07-20 | 上海星泰医药科技有限公司 | 一种左旋盐酸米那普仑缓释胶囊及其制备方法 |
| EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| MX2020002790A (es) | 2017-09-14 | 2020-08-20 | Evonik Operations Gmbh | Polimero y forma de dosis con propiedades de liberacion sostenida y resistencia contra la influencia de etanol. |
| EP3485879A1 (en) * | 2017-11-17 | 2019-05-22 | Maat Pharma | Pharmaceutical oral formulation comrpsing bacteria |
| WO2019170485A1 (en) | 2018-03-09 | 2019-09-12 | Evonik Röhm Gmbh | Polymer mixture with resistance against the influence of ethanol |
| JP2025508982A (ja) * | 2022-03-03 | 2025-04-10 | サイプルメド ゲーエムベーハー | 治療用ペプチドおよびタンパク質の改善された経口医薬製剤 |
| IL320492A (en) | 2022-10-25 | 2025-06-01 | Veradermics Incorporated | Compositions and methods of use for modified release minoxidil |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08143476A (ja) * | 1994-11-18 | 1996-06-04 | Japan Tobacco Inc | 薬物放出制御膜及び固形製剤 |
| FR2759293B1 (fr) * | 1997-02-11 | 1999-04-30 | Ethypharm Lab Prod Ethiques | Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie |
| US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| CA2459976A1 (en) * | 2001-09-26 | 2003-04-03 | Penwest Pharmaceuticals Company | Opioid formulations having reduced potential for abuse |
| DE10211289A1 (de) * | 2002-03-14 | 2003-09-25 | Basf Ag | Kombination von Polyvinylacetat von wasserunlöslichen, säureunlöslichen oder alkaliunlöslichen Polymeren zur Hestellung von Filmüberzügen mit sehr kontrollierter Freisetzung und hoher Stabilität |
| WO2003086353A1 (en) * | 2002-04-05 | 2003-10-23 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
| AU2004285284B2 (en) * | 2003-10-31 | 2010-03-25 | Hexal Ag | A process for the preparation of an active-ingredient-containing formulation with a coating |
| BRPI0606339A2 (pt) * | 2005-01-28 | 2009-06-16 | Euro Celtique Sa | formas farmacêuticas resistentes a álcool |
| DE102005024614A1 (de) * | 2005-05-25 | 2006-11-30 | Röhm Gmbh | Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug |
-
2007
- 2007-09-25 PL PL07820536T patent/PL2187875T3/pl unknown
- 2007-09-25 SI SI200731078T patent/SI2187875T1/sl unknown
- 2007-09-25 US US12/678,429 patent/US9555006B2/en not_active Expired - Fee Related
- 2007-09-25 MX MX2010003036A patent/MX2010003036A/es active IP Right Grant
- 2007-09-25 CA CA2699224A patent/CA2699224C/en not_active Expired - Fee Related
- 2007-09-25 CN CN200780100722.2A patent/CN101801356B/zh not_active Expired - Fee Related
- 2007-09-25 KR KR1020107006073A patent/KR101454056B1/ko not_active Expired - Fee Related
- 2007-09-25 JP JP2010525209A patent/JP5204846B2/ja not_active Expired - Fee Related
- 2007-09-25 EP EP07820536A patent/EP2187875B1/en active Active
- 2007-09-25 WO PCT/EP2007/060130 patent/WO2009036811A1/en not_active Ceased
- 2007-09-25 ES ES07820536T patent/ES2393805T3/es active Active
- 2007-09-25 BR BRPI0722042A patent/BRPI0722042B8/pt not_active IP Right Cessation
-
2010
- 2010-02-10 IL IL203870A patent/IL203870A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| PL2187875T3 (pl) | 2013-01-31 |
| CN101801356A (zh) | 2010-08-11 |
| IL203870A (en) | 2015-02-26 |
| EP2187875B1 (en) | 2012-09-05 |
| BRPI0722042A2 (pt) | 2014-03-25 |
| EP2187875A1 (en) | 2010-05-26 |
| SI2187875T1 (sl) | 2012-12-31 |
| WO2009036811A1 (en) | 2009-03-26 |
| BRPI0722042B1 (pt) | 2019-12-10 |
| CN101801356B (zh) | 2016-10-19 |
| KR20100063067A (ko) | 2010-06-10 |
| US20100221324A1 (en) | 2010-09-02 |
| US9555006B2 (en) | 2017-01-31 |
| CA2699224A1 (en) | 2009-03-26 |
| KR101454056B1 (ko) | 2014-10-27 |
| ES2393805T3 (es) | 2012-12-28 |
| JP2010539196A (ja) | 2010-12-16 |
| CA2699224C (en) | 2014-12-16 |
| BRPI0722042B8 (pt) | 2022-07-05 |
| JP5204846B2 (ja) | 2013-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010003036A (es) | Composicion farmaceutica de liberacion controlada ph dependiente para no opioides con resistencia a la influencia del etanol. | |
| MX2010003032A (es) | Composicion farmaceutica opioide de liberacion controlada ph dependiente con resistencia contra la influencia del etanol. | |
| BRPI0823128B8 (pt) | composição farmacêutica de liberação controlada dependente do ph para não opioides com resistência contra a influência de etanol, e processo para sua preparação | |
| BRPI0823096B8 (pt) | composição farmacêutica de opióide de liberação controlada, dependente do ph, com resistência contra a influência do etanol, processo para sua preparação, e seu uso | |
| MX2011009667A (es) | Composición farmacéutica de liberación controlada con resistencia a la influencia de etanol mediante el uso de un revestimiento compuesto de polímeros de vinilo neutrales y excipientes. | |
| MX2011009669A (es) | Composición farmacéutica de liberación controlada con resistencia a la influencia de etanol mediante un revestimiento compuesto de una mezcla polimérica y excipientes. | |
| WO2007070649A3 (en) | Antimicrobial coating system | |
| WO2007006353A3 (de) | Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten | |
| MX339671B (es) | Forma oral solida con perfil de liberacion dual que contiene particulas multiples. | |
| WO2009031295A1 (ja) | 薬剤徐放性ステント | |
| WO2009113703A3 (en) | Orally-disintegrating solid preparation | |
| WO2009028495A1 (ja) | 真菌性皮膚炎用剤 | |
| WO2010125323A8 (en) | Biocidal composition | |
| BRPI0907194A2 (pt) | Composição de revestimento, e, uso de copolímero | |
| EP2664595A3 (en) | Plasticizer-containing hardening accelerator composition | |
| WO2009074520A3 (de) | Copolymer und ophthalmologische zusammensetzung | |
| WO2012085043A3 (en) | Rapidly disintegrating, solid coated dosage form | |
| RU2014101227A (ru) | Композиция покрытия, подходящая для фармацевтических или нутрицевтических лекарственных форм | |
| HRP20201880T1 (hr) | Transdermalni terapijski sustav namijenjen primjeni aktivne tvari | |
| MX356579B (es) | Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. | |
| WO2009057980A3 (en) | Photochromic compositions and photochromic films | |
| MX376383B (es) | Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol | |
| BRPI0810335A2 (pt) | "pó depolímero redispersável, dispersão aquosa, composição de polímero e uso da composição de polímero" | |
| WO2008071407A3 (de) | Beschichtete pellets | |
| TW200616922A (en) | Use of vinyl chloride-ethylene copolymers for imparting water repellency to construction materials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |